Metabolic changes with antihypertensive therapy of the salt-sensitive patient

O. Bryan Holland, Peter E. Pool

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Recent evidence suggests that metabolic changes that occur with antihypertensive agents may influence cardiovascular risk. Diuretic therapy is particularly appropriate for the salt-sensitive hypertensive patient. However, diuretic-induced electrolyte abnormalities may lead to ventricular arrhythmias, even in patients with uncomplicated essential hypertension. Antihypertensive drugs may change circulating lipoprotein levels, which may influence the development of atherosclerosis. Therefore, serum cholesterol and triglyceride levels should be monitored when antihypertensive drugs are administered that can cause hyperlipidemia. Weight reduction and diet therapy should be used because these may have a greater effect on reducing hyperlipidemia, though choice of antihypertensive agents is important. In addition, glucose tolerance may worsen with thiazide therapy, perhaps because newer evidence suggests that insulin resistance is common in essential hypertension. This glucose intolerance may be corrected with potassium repletion or substitution of bumetanide for thiazide. The calcium antagonists may be substituted for diuretic therapy, or other classes of antihypertensive drugs may be used with a reduced dose of diuretic drug if these metabolic changes persist. Thus, attention to metabolic changes may be as important as blood pressure reduction in treatment of the salt-sensitive hypertensive patient.

Original languageEnglish (US)
JournalThe American Journal of Cardiology
Volume61
Issue number16
DOIs
StatePublished - Jun 15 1988

Fingerprint

Antihypertensive Agents
Diuretics
Salts
Thiazides
Hyperlipidemias
Reducing Diet
Bumetanide
Diet Therapy
Therapeutics
Glucose Intolerance
Electrolytes
Lipoproteins
Insulin Resistance
Cardiac Arrhythmias
Atherosclerosis
Potassium
Triglycerides
Cholesterol
Blood Pressure
Calcium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Metabolic changes with antihypertensive therapy of the salt-sensitive patient. / Holland, O. Bryan; Pool, Peter E.

In: The American Journal of Cardiology, Vol. 61, No. 16, 15.06.1988.

Research output: Contribution to journalArticle

@article{3aa1d6dec0f54312bd413f5e7ac16be7,
title = "Metabolic changes with antihypertensive therapy of the salt-sensitive patient",
abstract = "Recent evidence suggests that metabolic changes that occur with antihypertensive agents may influence cardiovascular risk. Diuretic therapy is particularly appropriate for the salt-sensitive hypertensive patient. However, diuretic-induced electrolyte abnormalities may lead to ventricular arrhythmias, even in patients with uncomplicated essential hypertension. Antihypertensive drugs may change circulating lipoprotein levels, which may influence the development of atherosclerosis. Therefore, serum cholesterol and triglyceride levels should be monitored when antihypertensive drugs are administered that can cause hyperlipidemia. Weight reduction and diet therapy should be used because these may have a greater effect on reducing hyperlipidemia, though choice of antihypertensive agents is important. In addition, glucose tolerance may worsen with thiazide therapy, perhaps because newer evidence suggests that insulin resistance is common in essential hypertension. This glucose intolerance may be corrected with potassium repletion or substitution of bumetanide for thiazide. The calcium antagonists may be substituted for diuretic therapy, or other classes of antihypertensive drugs may be used with a reduced dose of diuretic drug if these metabolic changes persist. Thus, attention to metabolic changes may be as important as blood pressure reduction in treatment of the salt-sensitive hypertensive patient.",
author = "Holland, {O. Bryan} and Pool, {Peter E.}",
year = "1988",
month = "6",
day = "15",
doi = "10.1016/0002-9149(88)91106-X",
language = "English (US)",
volume = "61",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Metabolic changes with antihypertensive therapy of the salt-sensitive patient

AU - Holland, O. Bryan

AU - Pool, Peter E.

PY - 1988/6/15

Y1 - 1988/6/15

N2 - Recent evidence suggests that metabolic changes that occur with antihypertensive agents may influence cardiovascular risk. Diuretic therapy is particularly appropriate for the salt-sensitive hypertensive patient. However, diuretic-induced electrolyte abnormalities may lead to ventricular arrhythmias, even in patients with uncomplicated essential hypertension. Antihypertensive drugs may change circulating lipoprotein levels, which may influence the development of atherosclerosis. Therefore, serum cholesterol and triglyceride levels should be monitored when antihypertensive drugs are administered that can cause hyperlipidemia. Weight reduction and diet therapy should be used because these may have a greater effect on reducing hyperlipidemia, though choice of antihypertensive agents is important. In addition, glucose tolerance may worsen with thiazide therapy, perhaps because newer evidence suggests that insulin resistance is common in essential hypertension. This glucose intolerance may be corrected with potassium repletion or substitution of bumetanide for thiazide. The calcium antagonists may be substituted for diuretic therapy, or other classes of antihypertensive drugs may be used with a reduced dose of diuretic drug if these metabolic changes persist. Thus, attention to metabolic changes may be as important as blood pressure reduction in treatment of the salt-sensitive hypertensive patient.

AB - Recent evidence suggests that metabolic changes that occur with antihypertensive agents may influence cardiovascular risk. Diuretic therapy is particularly appropriate for the salt-sensitive hypertensive patient. However, diuretic-induced electrolyte abnormalities may lead to ventricular arrhythmias, even in patients with uncomplicated essential hypertension. Antihypertensive drugs may change circulating lipoprotein levels, which may influence the development of atherosclerosis. Therefore, serum cholesterol and triglyceride levels should be monitored when antihypertensive drugs are administered that can cause hyperlipidemia. Weight reduction and diet therapy should be used because these may have a greater effect on reducing hyperlipidemia, though choice of antihypertensive agents is important. In addition, glucose tolerance may worsen with thiazide therapy, perhaps because newer evidence suggests that insulin resistance is common in essential hypertension. This glucose intolerance may be corrected with potassium repletion or substitution of bumetanide for thiazide. The calcium antagonists may be substituted for diuretic therapy, or other classes of antihypertensive drugs may be used with a reduced dose of diuretic drug if these metabolic changes persist. Thus, attention to metabolic changes may be as important as blood pressure reduction in treatment of the salt-sensitive hypertensive patient.

UR - http://www.scopus.com/inward/record.url?scp=0023937657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023937657&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(88)91106-X

DO - 10.1016/0002-9149(88)91106-X

M3 - Article

C2 - 3289352

AN - SCOPUS:0023937657

VL - 61

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 16

ER -